Clinical Trial Update: 64Cu-DOTATATE-PET for Lyme Neuroborreliosis [NA]

View source ↗

Summary

Clinical trial evaluating 64Cu-DOTATATE-PET imaging for Lyme neuroborreliosis is currently recruiting at Rigshospitalet, Denmark.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Neuroborreliosis

Drugs mentioned

• 64Cu-DOTATATE-PET (64Cu-DOTATATE)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Borrelia Burgdorferi Neuroborreliosis | NA | Status: RECRUITING